Cardiovascular Surgery

This channel includes news and new technology innovations for cardiac surgery. This includes coronary bypass grafts, surgical valve replacements.

The Parasym Salustim device ear clip stimulates the vagus nerve, which was found to reduced AF burden compared with a sham procedure in the TREAT AF trial.

The Parasym Salustim device ear clip stimulates the vagus nerve, which was found to reduced AF burden compared with a sham procedure in the TREAT AF trial. 

News | Atrial Fibrillation | May 13, 2019

May 13, 2019 — A randomized clinical trial effectively used nerve stimulation through an ear clip to reduce...

ProxiCor Extracellular Matrix Reduces Complications, Readmissions Following Pericardial Reconstruction
News | Stem Cell Therapies | April 19, 2019

April 19, 2019 — Aziyo Biologics Inc. announced the publication of results from its landmark RECON study in the...

The top five most important take-away presentations from the 2019 Society of Thoracic Surgeons (STS) annual meeting.
Blog | Cardiovascular Surgery | February 25, 2019

Here is what I thought were the top five most important take-away presentations from the 2019...

FDA Approves IDE Study for Foldax Biopolymer Heart Valve Platform
News | Heart Valve Technology | February 18, 2019

February 18, 2019 — Foldax Inc. announced the U.S. Food and Drug Administration (FDA) has granted investigative...

Medivis Launches SurgicalAR Augmented Reality Platform
Technology | Advanced Visualization | February 14, 2019

February 14, 2019 — Medical imaging and visualization company Medivis officially unveiled SurgicalAR, its...

SherpaPak Cardiac Transport System Cleared for Pediatric and Small Donor Hearts
Technology | Cardiovascular Surgery | February 01, 2019

February 1, 2019 — Paragonix Technologies Inc. recently received clearance from the U.S. Food and Drug...

Perceval Valve Offers Performance, Economic Advantages in Aortic Disease Treatment
News | Heart Valve Technology | January 29, 2019

January 29, 2019 — LivaNova PLC announced the publication of three separate studies highlighting the performance of...

New Appropriate Use Criteria Released for Peripheral Artery Interventions
News | Peripheral Artery Disease (PAD) | December 19, 2018

December 19, 2018 — A new set of appropriate use criteria (AUC) released Dec. 17 by a group of cardiovascular...

Videos | Advanced Visualization | December 12, 2018

This is an example of the FDA-cleared OpenSight augmented reality (AR) system for surgical planning from NovaRad at...

Transplanting Pig Hearts Into Humans One Step Closer. A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

News | Cardiovascular Surgery | December 11, 2018

December 11, 2018 — The scientific journal...

Valve Replacement Volume Key to Successful Patient Outcomes
News | Heart Valve Technology | November 02, 2018

November 2, 2018 — Hospitals that routinely perform a...

LivaNova Warns of Potential Infection Risks With 3T Heater-Cooler Systems
News | Cardiovascular Surgery | October 25, 2018

October 25, 2018 — On Oct. 18, 2018, LivaNova issued a...

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.

Feature | Heart Failure | October 19, 2018

October 19, 2018 — Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U....

Overlay Init